Analysis of PFS2 by subsequent therapy in KEYNOTE-361: Pembrolizumab (pembro) plus chemotherapy (chemo) or pembro alone versus chemo as 1L therapy for advanced urothelial carcinoma (UC).
JOURNAL OF CLINICAL ONCOLOGY, vol.39, no.6, 2021 (Journal Indexed in SCI)
Article / Abstract
Title of Journal :
JOURNAL OF CLINICAL ONCOLOGY